{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:21:18Z","timestamp":1792592478606,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015544","name":"King\u2019s College Hospital Charity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015544","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mitochondrion"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.mito.2020.12.010","type":"journal-article","created":{"date-parts":[[2020,12,30]],"date-time":"2020-12-30T20:39:11Z","timestamp":1609360751000},"page":"119-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"special_numbering":"C","title":["Mitochondrial dysfunction as a mechanistic biomarker in patients with non-alcoholic fatty liver disease (NAFLD)"],"prefix":"10.1016","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1089-1949","authenticated-orcid":false,"given":"Saima","family":"Ajaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"McPhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6353-630X","authenticated-orcid":false,"given":"Luigi","family":"Gnudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8048-1646","authenticated-orcid":false,"given":"Francesca M.","family":"Trovato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma","family":"Mujib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Napoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Carey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosh","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.mito.2020.12.010_b0005","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic Fatty Liver Disease: A Feature of the Metabolic Syndrome","volume":"50","author":"Marchesini","year":"2001","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.mito.2020.12.010_b0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.mito.2020.12.010_b0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease: Estes et al.","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.mito.2020.12.010_b0020","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/gutjnl-2016-312431","article-title":"Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease","volume":"66","author":"Rotman","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.mito.2020.12.010_b0025","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.redox.2017.11.016","article-title":"Synergistic interaction of fatty acids and oxysterols impairs mitochondrial function and limits liver adaptation during nafld progression","volume":"15","author":"Bellanti","year":"2018","journal-title":"Redox Biology"},{"key":"10.1016\/j.mito.2020.12.010_b0030","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1053\/j.gastro.2018.06.083","article-title":"Mitochondrial dysfunction and signaling in chronic liver diseases","volume":"155","author":"Mansouri","year":"2018","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.mito.2020.12.010_b0035","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1111\/liv.12523","article-title":"Are oxidative stress mechanisms the common denominator in the progression from hepatic steatosis towards non-alcoholic steatohepatitis (NASH)?","volume":"34","author":"Tariq","year":"2014","journal-title":"Liver Int"},{"issue":"1\u20132","key":"10.1016\/j.mito.2020.12.010_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/omi.2010.0073","article-title":"Validation of the use of peripheral blood mononuclear cells as surrogate model for skeletal muscle tissue in nutrigenomic studies","volume":"15","author":"Rudkowska","year":"2011","journal-title":"OMICS"},{"issue":"6","key":"10.1016\/j.mito.2020.12.010_b0045","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ebiom.2015.04.002","article-title":"Altered Mitochondrial Function, Mitochondrial DNA and Reduced Metabolic Flexibility in Patients With Diabetic Nephropathy","volume":"2","author":"Czajka","year":"2015","journal-title":"EBioMedicine"},{"issue":"11","key":"10.1016\/j.mito.2020.12.010_b0050","doi-asserted-by":"crossref","first-page":"850","DOI":"10.18632\/aging.100618","article-title":"Relationships between human vitality and mitochondrial respiratory parameters, reactive oxygen species production and dNTP levels in peripheral blood mononuclear cells","volume":"5","author":"Maynard","year":"2013","journal-title":"Aging"},{"issue":"1","key":"10.1016\/j.mito.2020.12.010_b0055","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/1358863X14521315","article-title":"Relation of mitochondrial oxygen consumption in peripheral blood mononuclear cells to vascular function in type 2 diabetes mellitus","volume":"19","author":"Hartman","year":"2014","journal-title":"Vasc Med"},{"issue":"5","key":"10.1016\/j.mito.2020.12.010_b0060","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1309\/RTPM1PY6YGBL2G2R","article-title":"Pathology of Nonalcoholic Fatty Liver Disease","volume":"128","author":"Yeh","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.mito.2020.12.010_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2017.05.005","article-title":"Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases","volume":"100","author":"Incalza","year":"2018","journal-title":"Vascular Pharmacology"},{"issue":"5","key":"10.1016\/j.mito.2020.12.010_b0070","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1586\/14737159.8.5.617","article-title":"Metabolomics-based methods for early disease diagnostics","volume":"8","author":"Gowda","year":"2008","journal-title":"Expert Review of Molecular Diagnostics"},{"key":"10.1016\/j.mito.2020.12.010_b0075","doi-asserted-by":"crossref","first-page":"341","DOI":"10.12659\/AOT.913800","article-title":"Metabolomic Characterization of Human Model of Liver Rejection Identifies Aberrancies Linked to Cyclooxygenase (COX) and Nitric Oxide Synthase (NOS)","volume":"24","author":"Skill","year":"2019","journal-title":"Ann Transplant"},{"issue":"7","key":"10.1016\/j.mito.2020.12.010_b0080","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/s41591-018-0126-3","article-title":"Microbiome metabolomics reveals new drivers of human liver steatosis","volume":"24","author":"Delzenne","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.mito.2020.12.010_b0090","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1042\/CS20140101","article-title":"The Bioenergetic Health Index: a new concept in mitochondrial translational research","volume":"127","author":"Chacko","year":"2014","journal-title":"Clin. Sci."},{"key":"10.1016\/j.mito.2020.12.010_b0095","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-1-60761-720-4_4","article-title":"Assessment of mitochondrial dysfunction in lymphocytes of patients with systemic lupus erythematosus","volume":"900","author":"Perl","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.mito.2020.12.010_b0100","first-page":"118","article-title":"Shiva Platelet mitochondrial function: from regulation of thrombosis to biomarker of disease Biochem","volume":"41","author":"Zharikov","year":"2013","journal-title":"Soc. Trans."},{"key":"10.1016\/j.mito.2020.12.010_b0105","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ebiom.2019.10.011","article-title":"CD8+ T cells from patients with cirrhosis display a phenotype that may contribute to cirrhosis-associated immune dysfunction","volume":"49","author":"Leboss\u00e9","year":"2019","journal-title":"EBioMedicine"},{"issue":"907","key":"10.1016\/j.mito.2020.12.010_b0110","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1098\/rspb.1954.0024","article-title":"Mechanism of action of carbon tetrachloride on liver cells","volume":"142","author":"Christie","year":"1954","journal-title":"Proc. R. Soc. Lond. B Biol. Sci."},{"issue":"5","key":"10.1016\/j.mito.2020.12.010_b0115","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1053\/gast.2001.23256","article-title":"Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities","volume":"120","author":"Sanyal","year":"2001","journal-title":"Gastroenterology"},{"issue":"5-6","key":"10.1016\/j.mito.2020.12.010_b0120","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.mito.2004.07.015","article-title":"Mitochondrial dysfunction in liver disease and organ transplantation","volume":"4","author":"Hassanein","year":"2004","journal-title":"Mitochondrion"},{"issue":"4","key":"10.1016\/j.mito.2020.12.010_b0125","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jhep.2018.06.023","article-title":"Urea cycle dysregulation in non-alcoholic fatty liver disease","volume":"69","author":"De Chiara","year":"2018","journal-title":"Journal of Hepatology"},{"issue":"Suppl 1","key":"10.1016\/j.mito.2020.12.010_b0130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s40265-018-1020-5","volume":"79","author":"Canbay","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.mito.2020.12.010_b0135","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.mehy.2018.02.010","article-title":"Ammonia: A novel target for the treatment of non-alcoholic steatohepatitis","volume":"113","author":"Thomsen","year":"2018","journal-title":"Medical Hypotheses"},{"issue":"3","key":"10.1016\/j.mito.2020.12.010_b0140","doi-asserted-by":"crossref","first-page":"G355","DOI":"10.1152\/ajpgi.00303.2013","article-title":"Carbamoyl phosphate synthetase-1 is a rapid turnover biomarker in mouse and human acute liver injury","volume":"307","author":"Weerasinghe","year":"2014","journal-title":"American Journal of Physiology-Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.mito.2020.12.010_b0145","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1097\/01.CCM.0000230240.02216.21","article-title":"Carbamoyl phosphate synthase 1: a marker of mitochondrial damage and depletion in the liver during sepsis","volume":"34","author":"Crouser","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.mito.2020.12.010_b0150","first-page":"533","article-title":"Release of the mitochondrial enzyme carbamoyl phosphate synthase 1 under septic condition","volume":"23","author":"Struck","year":"2005","journal-title":"Shock"},{"issue":"2","key":"10.1016\/j.mito.2020.12.010_b0155","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/apm.12917","article-title":"Carbamoyl phosphate synthetase 1 (CPS1) as a prognostic marker in chronic hepatitis C infection","volume":"127","author":"El-Sheikh","year":"2019","journal-title":"APMIS"},{"issue":"12","key":"10.1016\/j.mito.2020.12.010_b0160","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.2337\/db14-0595","article-title":"Circulating FGF21 Is Liver Derived and Enhances Glucose Uptake During Refeeding and Overfeeding","volume":"63","author":"Markan","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.mito.2020.12.010_b0165","doi-asserted-by":"crossref","first-page":"9729107","DOI":"10.1155\/2017\/9729107","article-title":"Diagnostic value of CK-18, FGF-21, and related biomarker panel in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"2017","author":"He","year":"2017","journal-title":"Biomed Res Int"}],"container-title":["Mitochondrion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567724920302415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567724920302415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:29:48Z","timestamp":1761589788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567724920302415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":32,"alternative-id":["S1567724920302415"],"URL":"https:\/\/doi.org\/10.1016\/j.mito.2020.12.010","relation":{},"ISSN":["1567-7249"],"issn-type":[{"value":"1567-7249","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial dysfunction as a mechanistic biomarker in patients with non-alcoholic fatty liver disease (NAFLD)","name":"articletitle","label":"Article Title"},{"value":"Mitochondrion","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mito.2020.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. and Mitochondria Research Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}